| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Yavetz Gilad | EXEC. CHAIRMAN OF THE BOARD, Director | C/O ENLIGHT RENEWABLE ENERGY LTD., 13 AMAL ST. AFEK INDUSTRIAL PARK, ROSH HAAYIN, ISRAEL | /s/ Helit Megido as attorney-in-fact for Gilad Yavetz | 18 Mar 2026 | 0002108306 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | ENLT | Ordinary shares, NIS 0.1 par value per share | 889,947 | 18 Mar 2026 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | ENLT | Performance-Based RSUs | 18 Mar 2026 | Ordinary shares, NIS 0.1 par value per share | 76,055 | Direct | F2 | |||||||
| holding | ENLT | Stock Options (right to buy) | 18 Mar 2026 | Ordinary shares, NIS 0.1 par value per share | 352,207 | $23.22 | Direct | F3, F4 | ||||||
| holding | ENLT | Stock Options (right to buy) | 18 Mar 2026 | Ordinary shares, NIS 0.1 par value per share | 345,927 | $27.33 | Direct | F5, F6 |
| Id | Content |
|---|---|
| F1 | Includes (i) 65,268 restricted share units granted on April 17, 2024, with 21,756 vesting on each of April 17, 2026, April 17, 2027, and April 17, 2028; and (ii) 6,726 restricted share units granted on October 1, 2025, with 1,681 vesting on October 1, 2026, 1,682 vesting on October 1, 2027, 1,681 vesting on October 1, 2028, and 1,682 vesting on October 1, 2029. Each restricted share unit represents a contingent right to receive one ordinary share of the Company. |
| F2 | Performance-based RSUs ("PSUs") were granted on October 1, 2025 and vest in four annual tranches beginning 12 months after the grant date, subject to continued service as an office holder and achievement of performance metrics for the preceding calendar year. The metrics, Total Income and Revenues, and Adjusted EBITDA (each as reported in the Company's Annual Report on Form 20-F), are measured against the midpoint of the Company's forecast published at the start of the applicable performance year. Achievement of 90% of the target yields 50% vesting for that metric's portion of the tranche, with linear interpolation for achievement between 90% and 100%. Metrics are weighted equally and evaluated independently; overperformance in one cannot offset the other. Each PSU represents a contingent right to receive one ordinary share of the Company upon vesting. |
| F3 | Stock options were granted on September 30, 2021, with 8,457 having vested on December 30, 2022, 31,250 having vested on March 30, 2023, 31,250 having vested on June 30, 2023, 31,250 having vested on September 30, 2023, 50,000 having vested on December 30, 2023, 50,000 having vested on March 30, 2023, 50,000 having vested on June 30, 2023, 50,000 having vested on September 30, 2024, 12,500 having vested on December 30, 2024, 12,500 having vested on March 30, 2025, 12,500 having vested on June 30, 2025, and 12,500 having vested on September 30, 2025. |
| F4 | Represents an exercise price of NIS 71.89, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026. |
| F5 | Stock options were granted on October 1, 2025, with 86,481 vesting on October 1, 2026, and 86,482 vesting on each of October 1, 2027, October 1, 2028, and October 1, 2029. |
| F6 | Represents an exercise price of NIS 84.60, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026. |
Exhibit List: Exhibit 24 - Power of Attorney by Gilad Yavetz